Company Filing History:
1 out of 12 
1 out of 1 Years Active: 1988
Title: Gabriella Klamar – Innovator in Enzyme Immobilization
Introduction
Gabriella Klamar is a remarkable inventor based in Budapest, Hungary. She has made significant contributions to the field of enzyme technology with her innovative approach to the immobilization of glucoamylase, a crucial enzyme used in various industrial applications. With her expertise and creativity, she has secured a patent that demonstrates her dedication to advancing scientific knowledge.
Latest Patents
Gabriella holds a patent titled "Process for Immobilization of Glucoamylase." This invention outlines a method whereby glucoamylase is immobilized using a carbodiimide on a polymer containing amino or carboxy functional groups. Depending on the functional groups present in the polymer, different methods are applied to achieve effective immobilization of the enzyme. The polymers used in her process are derived from materials such as acrylic acid, methacrylic acid, acrylamide, methacrylamide, N-amino-ethyl-acrylamide, and N-amino ethyl methacrylamide, utilizing a cross-linking agent of acrylic or allylic type.
Career Highlights
Throughout her career, Gabriella Klamar has worked at notable companies such as Reanal Finomvegyszergyar and Szeszipari Kutatointezet. Her experiences at these research institutions have provided her with the opportunity to innovate and collaborate with other talented professionals in her field.
Collaborations
Gabriella has had the pleasure of collaborating with esteemed coworkers including Laszlo Boross and Ivan Darozi. These partnerships underscore her commitment to teamwork and the advancement of enzyme technology. Their combined expertise contributes to the successful application of her patented technologies.
Conclusion
Gabriella Klamar's contributions to the field of enzyme immobilization reflect her passion for innovation and scientific advancement. Her patent not only showcases her skills as an inventor but also highlights the importance of collaboration in the research community. As she continues to build her career, Gabriella is sure to remain a significant figure in the world of biotechnology.